BTG (BTG)

Sector: Pharma and Biotech     Index: FTSE 250
-0.09%
-0.50p
559.00p
09:45 08/12/16
Apply Now
Your capital is at risk
559.00p
09:45 08/12/16
DAILY VARIATION
-0.09%
-0.50p
VOLUME
51,645
REAL TIME BATS
561.50p
09:51 08/12/16
0.27%
1.50p
DATA
52 Week High
728.00p
52 Week Low
559.50p
Shares Issued
385.09m
Market Cap
£2,152.65m
RiskGrade
n/a
Beta
0.64
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 12.6% 14.0%
ROCE 27.0%
Latest F'cast
P/E 25.5 27.0
PEG 0.6 4.5
Pr/Revenue 4.8 3.9
Pr/Book 2.5
Latest F'cast
Revenue 21.7% 11.3%
PBT 115.4% n/a
EPS 39.5% -7.9%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2012-03-31 197.00 23.00 11.40p 29.3 0.0 1,040% n/a 0.0%
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%
2016-03-31 447.50 57.50 21.90p 28.4 0.7 39% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-03-31 549.51 76.69 23.09p 27.0 5.0 5% 0.00p 0.0%
2018-03-31 646.12 137.71 32.58p 18.6 0.5 41% 0.00p 0.0%

Regulatory News

slide to see more
Total Voting Rights 01-Dec-16 13:34
Holding(s) in Company 25-Nov-16 16:59
Half-year Report 15-Nov-16 07:05

Newspaper Links

No results found